Mengxia X. Li
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Integrating brain organoids, meningeal immunity, and glymphatic dynamics: toward modeling neuroimmune clearance and crosstalk in disease.
Journal: Frontiers in immunology
Published: July 08, 2026
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial.
Journal: JAMA
Published: June 17, 2026
Case Report: Locally advanced primary esophageal melanoma with early brain metastasis.
Journal: Frontiers in oncology
Published: May 14, 2026
Targeting CD8+ T cell-derived granzyme K alleviates radiation-induced pulmonary fibrosis by attenuating senescence and SASP.
Journal: Archives of biochemistry and biophysics
Published: April 22, 2026
Regulation of exosomal miR-513a and miR-149 expression by APE1 in PD-L1 and TCR immune regulation pathways to promote immune evasion in osteosarcoma.
Journal: Cancer genetics
Published: February 10, 2026
Targeting the APE1 hub: integrating DNA repair and redox signaling for precision management of inflammation-associated diseases.
Journal: Molecular biology reports
Published: January 27, 2026
Genomic characterization of DNA damage response pathway mutations reveals their adverse impact on EGFR-TKI efficacy in non-small cell lung cancer.
Journal: Respiratory research
Published: January 05, 2026
DNA base lesion-containing G-quadruplex mediates transcriptome reprogramming in EGFR-TKI resistance of non-small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 29, 2025
Clonal tracing of rare anal metastasis in esophageal squamous cell carcinoma: a case report with whole-exome sequencing and multimodal therapy.
Journal: Frontiers in immunology
Published: October 17, 2025
Harmonizing the DESTINY and Broadening the HORIZON of HER2 ADCs in the Face of Next-Generation HER2 TKI for the Treatment Options of HER2 mutations positive (HER2+) NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 25, 2025
Oncolytic virotherapy mobilizes tumor-resident, granzyme B-producing bystander CD4+ T cells to inhibit systemic microbial infection.
Journal: Molecular therapy. Oncology
Published: August 20, 2025
Last Updated: 09/26/2026